159 related articles for article (PubMed ID: 28459203)
1. Leptin acts on neoplastic behavior and expression levels of genes related to hypoxia, angiogenesis, and invasiveness in oral squamous cell carcinoma.
Sobrinho Santos EM; Guimarães TA; Santos HO; Cangussu LMB; de Jesus SF; Fraga CAC; Cardoso CM; Santos SHS; de Paula AMB; Gomez RS; Guimarães ALS; Farias LC
Tumour Biol; 2017 May; 39(5):1010428317699130. PubMed ID: 28459203
[TBL] [Abstract][Full Text] [Related]
2. Gallic acid modulates phenotypic behavior and gene expression in oral squamous cell carcinoma cells by interfering with leptin pathway.
Santos EMS; da Rocha RG; Santos HO; Guimarães TA; de Carvalho Fraga CA; da Silveira LH; Batista PR; de Oliveira PSL; Melo GA; Santos SH; de Paula AMB; Guimarães ALS; Farias LC
Pathol Res Pract; 2018 Jan; 214(1):30-37. PubMed ID: 29254802
[TBL] [Abstract][Full Text] [Related]
3. Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma.
Guimarães TA; Farias LC; Santos ES; de Carvalho Fraga CA; Orsini LA; de Freitas Teles L; Feltenberger JD; de Jesus SF; de Souza MG; Santos SH; de Paula AM; Gomez RS; Guimarães AL
Oncotarget; 2016 Aug; 7(34):55057-55068. PubMed ID: 27474170
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
5. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
[TBL] [Abstract][Full Text] [Related]
6. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
Harada K; Ferdous T; Harada T; Ueyama Y
Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058
[TBL] [Abstract][Full Text] [Related]
7. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
[TBL] [Abstract][Full Text] [Related]
8. Transcutaneous carbon dioxide suppresses epithelial-mesenchymal transition in oral squamous cell carcinoma.
Iwata E; Hasegawa T; Takeda D; Ueha T; Kawamoto T; Akisue T; Sakai Y; Komori T
Int J Oncol; 2016 Apr; 48(4):1493-8. PubMed ID: 26846904
[TBL] [Abstract][Full Text] [Related]
9. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
Harada K; Supriatno ; Yoshida H; Sato M
Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
[TBL] [Abstract][Full Text] [Related]
10. Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis.
Lin CW; Yang WE; Lee WJ; Hua KT; Hsieh FK; Hsiao M; Chen CC; Chow JM; Chen MK; Yang SF; Chien MH
Carcinogenesis; 2016 Jul; 37(7):712-722. PubMed ID: 27207653
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia suppresses E-cadherin and enhances matrix metalloproteinase-2 expression favoring esophageal carcinoma migration and invasion via hypoxia inducible factor-1 alpha activation.
Jing SW; Wang YD; Chen LQ; Sang MX; Zheng MM; Sun GG; Liu Q; Cheng YJ; Yang CR
Dis Esophagus; 2013 Jan; 26(1):75-83. PubMed ID: 22340517
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2.
Zeng Q; Tao X; Huang F; Wu T; Wang J; Jiang X; Kuang Z; Cheng B
Int J Mol Med; 2016 May; 37(5):1274-80. PubMed ID: 26986233
[TBL] [Abstract][Full Text] [Related]
14. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the antineoplastic activity of gallic acid in oral squamous cell carcinoma under hypoxic conditions.
Guimaraes TA; Farias LC; Fraga CA; Feltenberger JD; Melo GA; Coletta RD; Souza Santos SH; de Paula AM; Guimaraes AL
Anticancer Drugs; 2016 Jun; 27(5):407-16. PubMed ID: 26849170
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-specific protease 14 regulates cell proliferation and apoptosis in oral squamous cell carcinoma.
Chen X; Wu J; Chen Y; Ye D; Lei H; Xu H; Yang L; Wu Y; Gu W
Int J Biochem Cell Biol; 2016 Oct; 79():350-359. PubMed ID: 27592452
[TBL] [Abstract][Full Text] [Related]
17. Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma.
Fang LY; Wong TY; Chiang WF; Chen YL
J Oral Pathol Med; 2010 Apr; 39(4):342-8. PubMed ID: 20040021
[TBL] [Abstract][Full Text] [Related]
18. Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma.
Bhawal UK; Ozaki Y; Nishimura M; Sugiyama M; Sasahira T; Nomura Y; Sato F; Fujimoto K; Sasaki N; Ikeda MA; Tsuji K; Kuniyasu H; Kato Y
Oncology; 2005; 69(3):246-55. PubMed ID: 16127291
[TBL] [Abstract][Full Text] [Related]
19. miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1.
Wu YY; Chen YL; Jao YC; Hsieh IS; Chang KC; Hong TM
Angiogenesis; 2014 Jan; 17(1):247-60. PubMed ID: 24114198
[TBL] [Abstract][Full Text] [Related]
20. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
